Literature DB >> 15608590

Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States.

Jill E Koshiol1, Samantha A Laurent, Jeanne M Pimenta.   

Abstract

BACKGROUND: Little non-clinic-based data are available on incident genital warts rates and related healthcare use. GOAL: : The goal of this study was to describe the incidence and predictors of genital warts and associated healthcare utilization patterns among a group of privately insured patients in the United States. STUDY: Health claims were evaluated prospectively from 5,914,107 privately insured individuals.
RESULTS: The rate of new genital warts claims per 100,000 person-years at risk, age-standardized to the 2001 U.S. privately insured population, increased from 117.8 in 1998 to 205.0 in 2001. The highest rates were among 20- to 29-year-olds. The majority of claims came from dermatology and obstetrics/gynecology.
CONCLUSIONS: The incidence of genital warts, as measured by the rate of new claims, appears to be rising. Age associations with the rate of new genital warts claims differed by gender; these associations may be influenced by changes in health-seeking behavior, potentially driven by health awareness.

Entities:  

Mesh:

Year:  2004        PMID: 15608590     DOI: 10.1097/01.olq.0000145851.76025.ad

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  18 in total

1.  Risk factors for incident condyloma in a multinational cohort of men: the HIM study.

Authors:  Gabriella M Anic; Ji-Hyun Lee; Luisa L Villa; Eduardo Lazcano-Ponce; Christine Gage; Roberto José C Silva; Maria L Baggio; Manuel Quiterio; Jorge Salmerón; Mary R Papenfuss; Martha Abrahamsen; Heather Stockwell; Dana E Rollison; Yougui Wu; Anna R Giuliano
Journal:  J Infect Dis       Date:  2012-01-11       Impact factor: 5.226

2.  Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study.

Authors:  Gabriella M Anic; Ji-Hyun Lee; Heather Stockwell; Dana E Rollison; Yougui Wu; Mary R Papenfuss; Luisa L Villa; Eduardo Lazcano-Ponce; Christine Gage; Roberto José C Silva; Maria L Baggio; Manuel Quiterio; Jorge Salmerón; Martha Abrahamsen; Anna R Giuliano
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

3.  Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) .

Authors:  Dr M Dawar; Ms T Harris; Dr S McNeil
Journal:  Can Commun Dis Rep       Date:  2012-01-02

4.  [Conservative treatment of anogenital HPV infections].

Authors:  G Gross
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

5.  Prevalence of genital warts among sexually transmitted disease clinic patients-sexually transmitted disease surveillance network, United States, January 2010 to December 2011.

Authors:  Eloisa Llata; Mark Stenger; Kyle Bernstein; Sarah Guerry; Roxanne Kerani; River Pugsley; Preeti Pathela; Irina Tabidze; Hillard Weinstock
Journal:  Sex Transm Dis       Date:  2014-02       Impact factor: 2.830

6.  Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study.

Authors:  Anna R Giuliano; Ji-Hyun Lee; William Fulp; Luisa L Villa; Eduardo Lazcano; Mary R Papenfuss; Martha Abrahamsen; Jorge Salmeron; Gabriella M Anic; Dana E Rollison; Danelle Smith
Journal:  Lancet       Date:  2011-02-28       Impact factor: 79.321

7.  Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa.

Authors:  Nelly Mugo; Nana Akosua Ansah; Deborah Marino; Alfred Saah; Elizabeth I O Garner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 8.  [Polyphenon E. A new topical therapy for condylomata acuminata].

Authors:  G Gross
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

Review 9.  [Impact of prophylactic HPV vaccines on dermatology and venereology].

Authors:  G Gross
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

10.  Distribution of genital wart human papillomavirus genotypes in China: a multi-center study.

Authors:  Lihong Chang; Puwa Ci; Jufang Shi; Kan Zhai; Xiaoli Feng; Danny Colombara; Wei Wang; Youlin Qiao; Wen Chen; Yuping Wu
Journal:  J Med Virol       Date:  2013-07-16       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.